Cimatron's shares are publicly traded on the NASDAQ exchange and the TASE under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com
Safe Harbor Statement
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
Three months Nine months
ended ended
September 30, September 30,
2011 2010 2011 2010
Total revenue 9,619 8,745 28,488 25,061
Total cost of revenue 1,288 1,419 3,906 4,242
Gross profit 8,331 7,326 24,582 20,819
Research and development
expenses, net 1,654 1,493 4,708 4,322
Selling, general and
administrative expenses 5,928 5,354 17,654 15,771
Operating income 749 479 2,220 726
Financial income (expenses),
net (163) 236 (9) 54
Taxes on income (566) (376) (988) (256)
Other 1 1 (9) (7)
Net income 21 340 1,214 517
Less: Net (income) loss
attributable to the
noncontrolling interest (14) (20) 13 (19)
Net income attributable to
Cimatron's shareholders $ 7 $ 320 $ 1,227 $ 498
Net income per share - basic
and diluted $ 0.00 $ 0.04 $ 0.13 $ 0.06
Weighted average number of shares
outstanding
Basic EPS (in thousands) 9,300 8,961 9,235 9,014
Diluted EPS (in thousands) 9,315 8,961 9,284 9,014
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
Three months ended September 30,
2011 2010
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total
revenue 9,619 - 9,619 8,745 - 8,745
Total cost of
revenue (1) 1,288 (147) 1,141 1,419 (147) 1,272
Gross
profit 8,331 147 8,478 7,326 147 7,473
Research and
development
expenses, net 1,654 - 1,654 1,493 - 1,493
Selling, general and
administrative
expenses (1) 5,928 (99) 5,829 5,354 (99) 5,255
Operating
income 749 246 995 479 246 725
Financial income
(expenses), net (163) - (163) 236 - 236
Taxes on
income (2) (566) 565 (1) (376) 308 (68)
Other 1 - 1 1 - 1
Net income 21 811 832 340 554 894
Less: Net (income)
loss attributable
to the
noncontrolling
interest (14) - (14) (20) - (20)
Net income
attributable to
Cimatron's
shareholders $ 7 $ 811 $ 818 $ 320 $ 554 $ 874
Net income per
share - basic and
diluted $ 0.00 $ 0.09 $ 0.04 $ 0.10
Weighted average
number of shares
outstanding
Basic EPS (in
thousands) 9,300 9,300 8,961 8,961
Diluted EPS
(in
thousands) 9,315 9,315 8,961 8,961
